Laura Connelly-Smith
Overview
Explore the profile of Laura Connelly-Smith including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
879
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Carpenter P, Gooley T, Boiko J, Lee C, Burroughs L, Mehta R, et al.
Blood Adv
. 2024 Aug;
8(22):5829-5837.
PMID: 39167805
Since 2005, there has been a steady decline in chronic graft-versus-host disease (cGVHD) at the Fred Hutchinson Cancer Center. To better understand this phenomenon, we studied the risk of cGVHD...
2.
Murakami M, Connelly-Smith L, Spitzer T, Kassim A, Penza S, Al Malki M, et al.
Transplant Cell Ther
. 2024 Apr;
30(7):663-680.
PMID: 38642840
Data on recent bone marrow harvest (BMH) collections from the NMDP has shown that bone marrow (BM) quality has decreased based on total nucleated cell count in the product. To...
3.
Salit R, Lee S, Bhatt N, Carpenter P, Fan X, Armstrong A, et al.
Transplant Cell Ther
. 2024 Apr;
30(6):612.e1-612.e12.
PMID: 38561139
While curing a patient's underlying disease is the primary goal of physicians performing hematopoietic cell transplantation (HCT), the ultimate objective is to provide patients with optimal post-HCT quality of life....
4.
Holmberg L, Maloney D, Connelly-Smith L
Acta Haematol
. 2023 Sep;
147(3):300-309.
PMID: 37708877
Introduction: The success of autologous stem cell transplantation (ASCT) for treating non-Hodgkin's lymphoma (NHL) is limited by its high relapse rates. To reduce the risk of relapse, additional maintenance therapy...
5.
Connelly-Smith L, Gooley T, Roberts L, Mielcarek M, Linenberger M, Petersdorf E, et al.
Transplant Cell Ther
. 2023 Sep;
29(11):700.e1-700.e8.
PMID: 37659695
During the Coronavirus disease 2019 pandemic, cryopreservation of allogeneic donor stem cell products ensured the availability of products at the start of conditioning for hematopoietic cell transplantation (HCT). Following recommendations...
6.
Connelly-Smith L, Alquist C, Aqui N, Hofmann J, Klingel R, Onwuemene O, et al.
J Clin Apher
. 2023 Apr;
38(2):77-278.
PMID: 37017433
The American Society for Apheresis (ASFA) Journal of Clinical Apheresis (JCA) Special Issue Writing Committee is charged with reviewing, updating, and categorizing indications for the evidence-based use of therapeutic apheresis...
7.
Ullrich C, Baker K, Carpenter P, Flowers M, Gooley T, Stevens S, et al.
Transplant Cell Ther
. 2022 Dec;
29(3):200.e1-200.e8.
PMID: 36494015
With improved survival after hematopoietic cell transplantation (HCT), the number of individuals at risk for persistent or late effects is increasing. The importance of optimizing HCT survivor health and well-being...
8.
Manjappa S, Phi H, Lee L, Onstad L, Gill D, Connelly-Smith L, et al.
Transplant Cell Ther
. 2022 Sep;
28(11):784.e1-784.e9.
PMID: 36058550
Chronic graft-versus-host disease (cGVHD) and its management with immunosuppressive therapies increase the susceptibility to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, as well as progression to severe Coronavirus 19...
9.
Rashid N, Krakow E, Yeh A, Ueda Oshima M, Onstad L, Connelly-Smith L, et al.
Transplant Cell Ther
. 2022 Sep;
28(12):844.e1-844.e8.
PMID: 36057421
Grade III-IV acute graft-versus-host disease (aGVHD) is associated with high short-term morbidity and mortality following allogeneic hematopoietic cell transplantation (HCT). The long-term effects after recovery from grade III-IV aGVHD are...
10.
Holmberg L, Linenberger M, Connelly-Smith L
Transplant Cell Ther
. 2022 Aug;
28(11):754-759.
PMID: 36002104
A major barrier for proceeding to autologous stem cell transplantation (ASCT) is an inability to mobilize and collect an adequate number of peripheral blood (PB) stem cells (PBSC) for the...